Gene Therapy

uniQure N.V. (QURE) Financial Outlook – June 17, 2026

Quantitative analysis of QURE following a +75.5% surge driven by favorable FDA draft guidance on shared platform data for gene therapies, weighed against extreme overbought RSI, negative cash flows, and widening margin gaps.